Comparative Pharmacology
Head-to-head clinical analysis: CHRONULAC versus NULYTELY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHRONULAC versus NULYTELY.
CHRONULAC vs NULYTELY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is hydrolyzed by colonic bacteria to form low molecular weight acids (mainly lactic and acetic acid), which osmotically draw water into the colon, softening stools and increasing stool frequency. Additionally, lactulose decreases colonic pH, which traps ammonia (NH3) as ammonium (NH4+), reducing serum ammonia levels.
Polyethylene glycol (PEG) 3350 is an osmotic agent that induces diarrhea by drawing water into the gastrointestinal tract, thereby cleansing the bowel. Sodium sulfate and electrolytes (sodium, potassium, bicarbonate) are added to prevent fluid and electrolyte shifts.
10-30 mL orally once daily to twice daily; for acute constipation, 20-30 mL initially; for hepatic encephalopathy, 30-60 mL every 1-2 hours to achieve 2-3 soft stools daily.
4 liters orally of the reconstituted solution as a single dose for colonoscopy preparation, typically administered in divided doses (e.g., 240 mL every 10 minutes) until rectal effluent is clear. Alternatively, a split-dose regimen: half the solution evening before, half on the day of procedure.
None Documented
None Documented
Terminal elimination half-life approximately 1.5-2.5 hours in adults with normal renal function; may be prolonged to 4-8 hours in patients with renal impairment.
Not applicable; NULYTELY is not systemically absorbed in significant amounts, so a terminal elimination half-life is not defined. The drug acts locally in the gastrointestinal tract.
Primarily renal (as unchanged drug and metabolites): ~40-50% of dose excreted in urine within 24 hours; biliary/fecal elimination accounts for the remainder, with approximately 2-5% recovered in feces as parent compound.
NULYTELY (polyethylene glycol 3350) is minimally absorbed systemically (<0.06%). The primary route of elimination is fecal excretion of the intact polymer. Renal excretion is negligible (<0.02%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative